Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson, CH Conrad… - The American journal of …, 1996 - Elsevier
Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

Rationale and design of the third Vasodilator-Heart Failure Trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson… - American Journal of …, 1996 - experts.umn.edu
This study addresses the effects of early banding of the pulmonary trunk and subsequent
management of subaortic obstruction on the attainment of acceptable pre-Fontan …

Rationale and design of the third Vasodilator-Heart Failure Trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson… - American Journal of …, 1996 - ajconline.org
Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson… - The American Journal …, 1996 - europepmc.org
Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

[引用][C] Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without …

WE BODEN, S ZIESCHE, PE CARSON… - … American journal of …, 1996 - pascal-francis.inist.fr
Rationale and design of the third vasodilator-heart failure trial (V-HeFT III) : Felodipine as
adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic …

Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson… - The American …, 1996 - pubmed.ncbi.nlm.nih.gov
Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

Rationale and design of the third Vasodilator-Heart Failure Trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in …

WE Boden, S Ziesche, PE Carson, CH Conrad… - The American Journal of …, 1996 - infona.pl
Therapy with angiotensin-converting enzyme inhibitors and nonselective vasodilators
(hydralazine and isosorbide dinitrate) has become accepted treatment in patients with …

[引用][C] Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): Felodipine as adjunctive therapy to enalapril and loop diuretics with or without …

WE BODEN, S ZIESCHE, PE CARSON… - The American journal of …, 1996 - Elsevier